Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Aug;65(8):3011–3016. doi: 10.1128/iai.65.8.3011-3016.1997

Diphosphoryl lipid A from Rhodobacter sphaeroides inhibits complexes that form in vitro between lipopolysaccharide (LPS)-binding protein, soluble CD14, and spectrally pure LPS.

B W Jarvis 1, H Lichenstein 1, N Qureshi 1
PMCID: PMC175424  PMID: 9234747

Abstract

An early event in septic shock is the activation of macrophages by a complex consisting of lipopolysaccharide (LPS), LPS-binding protein (LBP), and the cell surface antigen CD14. The complexes that form between [3H]ReLPS (ReLPS is deep-rough-chemotype hexacyl LPS from E. coli D31m4), soluble CD14 (sCD14), and LBP were analyzed by two independent methods, native (nondenaturing) gel electrophoresis and size-exclusion high-performance liquid chromatography (HPLC). This is the first reported use of HPLC to purify and study LPS-protein complexes. The binding of [3H]ReLPS to LBP and sCD14 was inhibited by preincubation with diphosphoryl lipid A from Rhodobacter sphaeroides (RsDPLA), a potent LPS antagonist. In addition, [3H]ReLPS bound to LBP and to a truncated form of sCD14 [sCD14(1-152)] that contained the LPS binding domain. Binding to both proteins was blocked by RsDPLA. Thus, RsDPLA competes in a 1:1 ratio for the same or nearby binding sites on ReLPS complexes. Analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of aggregated ReLPS eluting from the HPLC indicated that only LBP, not sCD14, was bound to the aggregated ReLPS. This finding supports the binary model of LPS complex formation with LBP and sCD14.

Full Text

The Full Text of this article is available as a PDF (391.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aida Y., Kusumoto K., Nakatomi K., Takada H., Pabst M. J., Maeda K. An analogue of lipid A and LPS from Rhodobacter sphaeroides inhibits neutrophil responses to LPS by blocking receptor recognition of LPS and by depleting LPS-binding protein in plasma. J Leukoc Biol. 1995 Dec;58(6):675–682. doi: 10.1002/jlb.58.6.675. [DOI] [PubMed] [Google Scholar]
  2. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  3. Bone R. C., Fisher C. J., Jr, Clemmer T. P., Slotman G. J., Metz C. A., Balk R. A. Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med. 1989 May;17(5):389–393. [PubMed] [Google Scholar]
  4. Delude R. L., Fenton M. J., Savedra R., Jr, Perera P. Y., Vogel S. N., Thieringer R., Golenbock D. T. CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity. J Biol Chem. 1994 Sep 2;269(35):22253–22260. [PubMed] [Google Scholar]
  5. Delude R. L., Savedra R., Jr, Zhao H., Thieringer R., Yamamoto S., Fenton M. J., Golenbock D. T. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9288–9292. doi: 10.1073/pnas.92.20.9288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Galanos C., Lüderitz O., Westphal O. A new method for the extraction of R lipopolysaccharides. Eur J Biochem. 1969 Jun;9(2):245–249. doi: 10.1111/j.1432-1033.1969.tb00601.x. [DOI] [PubMed] [Google Scholar]
  7. Gegner J. A., Ulevitch R. J., Tobias P. S. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem. 1995 Mar 10;270(10):5320–5325. doi: 10.1074/jbc.270.10.5320. [DOI] [PubMed] [Google Scholar]
  8. Golenbock D. T., Hampton R. Y., Qureshi N., Takayama K., Raetz C. R. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem. 1991 Oct 15;266(29):19490–19498. [PubMed] [Google Scholar]
  9. Hailman E., Lichenstein H. S., Wurfel M. M., Miller D. S., Johnson D. A., Kelley M., Busse L. A., Zukowski M. M., Wright S. D. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med. 1994 Jan 1;179(1):269–277. doi: 10.1084/jem.179.1.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Henderson B., Poole S., Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev. 1996 Jun;60(2):316–341. doi: 10.1128/mr.60.2.316-341.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jack R. S., Grunwald U., Stelter F., Workalemahu G., Schütt C. Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria. Eur J Immunol. 1995 May;25(5):1436–1441. doi: 10.1002/eji.1830250545. [DOI] [PubMed] [Google Scholar]
  12. Juan T. S., Hailman E., Kelley M. J., Busse L. A., Davy E., Empig C. J., Narhi L. O., Wright S. D., Lichenstein H. S. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J Biol Chem. 1995 Mar 10;270(10):5219–5224. doi: 10.1074/jbc.270.10.5219. [DOI] [PubMed] [Google Scholar]
  13. Kirikae T., Schade F. U., Kirikae F., Qureshi N., Takayama K., Rietschel E. T. Diphosphoryl lipid A derived from the lipopolysaccharide (LPS) of Rhodobacter sphaeroides ATCC 17023 is a potent competitive LPS inhibitor in murine macrophage-like J774.1 cells. FEMS Immunol Med Microbiol. 1994 Sep;9(3):237–243. doi: 10.1111/j.1574-695X.1994.tb00499.x. [DOI] [PubMed] [Google Scholar]
  14. Kitchens R. L., Munford R. S. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J Biol Chem. 1995 Apr 28;270(17):9904–9910. doi: 10.1074/jbc.270.17.9904. [DOI] [PubMed] [Google Scholar]
  15. McGinley M. D., Narhi L. O., Kelley M. J., Davy E., Robinson J., Rohde M. F., Wright S. D., Lichenstein H. S. CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide. J Biol Chem. 1995 Mar 10;270(10):5213–5218. doi: 10.1074/jbc.270.10.5213. [DOI] [PubMed] [Google Scholar]
  16. Qureshi N., Honovich J. P., Hara H., Cotter R. J., Takayama K. Location of fatty acids in lipid A obtained from lipopolysaccharide of Rhodopseudomonas sphaeroides ATCC 17023. J Biol Chem. 1988 Apr 25;263(12):5502–5504. [PubMed] [Google Scholar]
  17. Qureshi N., Takayama K., Heller D., Fenselau C. Position of ester groups in the lipid A backbone of lipopolysaccharides obtained from Salmonella typhimurium. J Biol Chem. 1983 Nov 10;258(21):12947–12951. [PubMed] [Google Scholar]
  18. Qureshi N., Takayama K., Mascagni P., Honovich J., Wong R., Cotter R. J. Complete structural determination of lipopolysaccharide obtained from deep rough mutant of Escherichia coli. Purification by high performance liquid chromatography and direct analysis by plasma desorption mass spectrometry. J Biol Chem. 1988 Aug 25;263(24):11971–11976. [PubMed] [Google Scholar]
  19. Rose J. R., Christ W. J., Bristol J. R., Kawata T., Rossignol D. P. Agonistic and antagonistic activities of bacterially derived Rhodobacter sphaeroides lipid A: comparison with activities of synthetic material of the proposed structure and analogs. Infect Immun. 1995 Mar;63(3):833–839. doi: 10.1128/iai.63.3.833-839.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tobias P. S., Soldau K., Gegner J. A., Mintz D., Ulevitch R. J. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem. 1995 May 5;270(18):10482–10488. doi: 10.1074/jbc.270.18.10482. [DOI] [PubMed] [Google Scholar]
  21. Yu B., Wright S. D. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J Biol Chem. 1996 Feb 23;271(8):4100–4105. doi: 10.1074/jbc.271.8.4100. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES